Asarina Pharma AB (OSTO:ASAP) Operating Cash Flow per Share : kr-0.50 (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Asarina Pharma AB Operating Cash Flow per Share?

Asarina Pharma AB's operating cash flow per share for the six months ended in Dec. 2023 was kr-0.50. Asarina Pharma AB's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.50.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Asarina Pharma AB's Operating Cash Flow per Share or its related term are showing as below:

OSTO:ASAP's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Asarina Pharma AB Operating Cash Flow per Share Historical Data

The historical data trend for Asarina Pharma AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Operating Cash Flow per Share Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-3.34

-4.04

-2.12

-0.48

-0.49

Asarina Pharma AB Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial									-0.60	-0.11	-0.37	-	-0.50

Competitive Comparison of Asarina Pharma AB's Operating Cash Flow per Share

For the Biotechnology subindustry, Asarina Pharma AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asarina Pharma AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asarina Pharma AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Asarina Pharma AB's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Asarina Pharma AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Asarina Pharma AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-11.272	/	22.911
	=	-0.49

Asarina Pharma AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-11.35	/	22.641
	=	-0.50

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-0.50

Asarina Pharma AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (OSTO:ASAP) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB Headlines

No Headlines